Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies - Goldwater, Ronald; Hussaini, Azra; Bosch, Bill; Nemeth, Paul (Clinical pharmacokinetics, 2017)
Keywords: Abiraterone Acetate - blood; Abiraterone Acetate - chemistry; Abiraterone Acetate - pharmacokinetics; Adolescent; Adult; Androgens; Antineoplastic Agents - blood; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacokinetics; Area Under Curve; Bioavailability; Biological Availability; Cancer therapies; Confidence intervals; Consent; Cross-Over Studies; Design; Drug Compounding; Drug dosages; Healthy Volunteers; Humans; Internal Medicine; Male; Medicine; Medicine & Public Health; Metastasis; Middle Aged; Nonsteroidal anti-inflammatory drugs; Open access publishing; Original; Original Research Article; Pharmaceuticals; Pharmacology/Toxicology; Pharmacotherapy; Prostate cancer; Review boards; Studies; Therapeutic Equivalency; Young Adult; United States--US; Meloxicam; Healthy Male Subject; Abiraterone; Abiraterone Acetate; Dose Proportionality